Integer Holdings Corporation ITGR

Company Overview

Integer Holdings Corporation (NYSE: ITGR) is a medical device outsource manufacturing company that develops and manufactures components, subassemblies, finished medical devices, and specialized technologies for original equipment manufacturers (OEMs) and medical technology companies. The company operates primarily in the medical technology and healthcare manufacturing industries, with a focus on high-reliability, highly regulated products used in cardiovascular, neuromodulation, orthopedics, vascular, portable medical, and advanced surgical applications. Integer also develops batteries and power solutions used in implantable and non-implantable medical devices.

The company’s primary revenue drivers include contract manufacturing services, proprietary medical device technologies, and engineered components supplied to large global medical device companies. Integer serves customers across the cardiac rhythm management, electrophysiology, neurostimulation, orthopedic reconstruction, minimally invasive surgery, and portable medical device markets. Its strategic positioning is supported by long-term OEM relationships, regulatory and engineering expertise, vertically integrated manufacturing capabilities, and specialized know-how in implantable device technologies. Integer traces its roots to 1970 with the founding of Wilson Greatbatch Technologies, known for innovations in implantable batteries for pacemakers. The company later expanded through acquisitions and diversification into broader medical device outsourcing before rebranding as Integer Holdings Corporation in 2015.

Business Operations

Integer organizes its operations primarily through two reportable business segments: Medical and Non-Medical. The Medical segment represents the substantial majority of company revenue and includes manufacturing operations for cardio and vascular products, cardiac rhythm management and neuromodulation devices, advanced surgical systems, orthopedic implants and instruments, and portable medical technologies. Revenue is generated through long-term supply agreements, engineering development programs, and full-service manufacturing partnerships with major medical device OEMs. The Non-Medical segment has historically included electrochemistry and energy solutions serving niche industrial and environmental applications, though the company has increasingly focused its portfolio toward medical technologies.

Integer operates manufacturing, research, and engineering facilities across the United States, Mexico, Ireland, Switzerland, Malaysia, and other international locations. The company controls specialized manufacturing assets including precision machining, catheter development platforms, implantable battery technologies, and complex sterilization and assembly capabilities. Key operating subsidiaries and acquired businesses have included Lake Region Medical, which significantly expanded Integer’s catheter and minimally invasive device manufacturing capabilities, and Oscor, acquired to strengthen electrophysiology and access technologies. Integer maintains strategic relationships with major global medical device manufacturers and benefits from embedded supplier status within customers’ regulated product ecosystems.

Strategic Position & Investments

Integer’s strategic direction has centered on expanding its role as a scaled medical device outsourcing partner while increasing exposure to higher-growth and higher-margin markets such as electrophysiology, structural heart, neuromodulation, and advanced surgical technologies. The company has invested in manufacturing automation, catheter and delivery system capabilities, and capacity expansion initiatives intended to support demand from minimally invasive and cardiovascular device markets. Management has consistently emphasized operational excellence, supply chain optimization, and targeted investment in differentiated technologies that strengthen customer integration.

Major acquisitions have played a central role in Integer’s evolution. The acquisition of Lake Region Medical transformed the company into a larger diversified medical device manufacturer with expanded international operations and catheter-based technology capabilities. The acquisition of Oscor’s vascular portfolio further enhanced access device and electrophysiology offerings. Integer has also invested in advanced battery technologies, complex assemblies, and engineering services to support emerging medical applications. Public filings and investor materials indicate continued focus on markets benefiting from aging populations, increasing procedure volumes, and growth in minimally invasive therapies.

Geographic Footprint

Integer is headquartered in Plano, Texas, and maintains a broad operational footprint across North America, Europe, and Asia-Pacific. Its manufacturing and engineering network includes facilities in the United States, Mexico, Ireland, Switzerland, and Malaysia, among other locations. The company supports multinational medical device OEMs that distribute products globally, giving Integer indirect exposure to healthcare systems and medical markets worldwide.

The company’s operational presence in Ireland and Switzerland supports European medical technology customers and regulatory alignment within major healthcare markets, while facilities in Mexico and Malaysia contribute to manufacturing scale and cost efficiency. Integer’s international footprint is strategically important for supporting localized production, supply chain resilience, and customer proximity in highly regulated medical device sectors.

Leadership & Governance

Integer’s leadership team is focused on operational execution, customer partnership expansion, disciplined capital allocation, and long-term growth in specialized medical technologies. The company’s governance structure follows standard public-company practices, with oversight provided by a board of directors and executive leadership team experienced in medical devices, manufacturing, healthcare operations, and finance. Management has publicly emphasized innovation, quality systems, and strategic alignment with global medical device OEMs as core elements of the company’s operating philosophy.

Key executives include:

• Joseph W. Dziedzic – President and Chief Executive Officer
• Andrew S. Royal – Executive Vice President and Chief Financial Officer
• Jennifer M. Bolt – Executive Vice President, President of Cardio & Vascular
• Kristin A. Raduenz – Executive Vice President, Chief Human Resources Officer
• John A. Harris – Executive Vice President, President of Advanced Surgical, Orthopedics & Portable Medical
• R. Scott Huennekens – Chair of the Board of Directors

Information regarding leadership structure, segment reporting, acquisitions, and operational strategy has been consistently reflected in SEC filings, annual reports, investor presentations, and major financial reporting sources.